Intercept Comes in First With Liver Drug, But Race Isn’t Over

Bookmark
(Bloomberg Opinion) -- It’s good to come in first in drug development, though it’s not always a guarantee of long-term commercial success. 
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.